# Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA

> **NCT02110238** · NA · COMPLETED · sponsor: **Bioventus LLC** · enrollment: 421 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DEVICE:** Supartz
- **DEVICE:** Euflexxa

## Key facts

- **NCT ID:** NCT02110238
- **Lead sponsor:** Bioventus LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-11
- **Final completion:** 2015-02
- **Target enrollment:** 421 (ACTUAL)
- **Last updated:** 2021-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02110238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02110238, "Non-Inferiority Study Comparing 3 Weekly Injections of SUPARTZ® vs 3 Weekly Injections of Euflexxa® for Knee OA". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02110238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*